Stock listing
Pacific Edge Limited
Selected listing: PEB · NZX · NZD · NZ
Pacific Edge Limited (NZX:PEB), Health Technology. Latest release May 24, 2026: PEB: Revenue dropped sharply after Medicare loss; capital raised and draft…
- Ticker
- NZX:PEB
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NZX
- Currency
- NZD
About Pacific Edge Limited
The company focuses on developing innovative cancer diagnostics and related technologies. Its mission is to improve patient outcomes through advanced healthcare solutions.
Latest news from Pacific Edge Limited
PEB: Revenue dropped sharply after Medicare loss; capital raised and draft policy may restore growth
May 24, 2026
PEB: Draft Medicare coverage and reduced cash burn position the business for growth and profitability
May 10, 2026
PEB: Anticipated Medicare re-coverage and capital raise position for growth in cancer diagnostics
May 8, 2026
PEB: Medicare re-coverage and capital raise aim to unlock growth for Cxbladder diagnostics
May 7, 2026
Pacific Edge Test Volumes Rise 2.7% in Q4 on Payer Expansion
April 9, 2026
Events
Replays
Pacific Edge Limited (PEB) Q2 2026 Earnings Call
Mon, Nov 24, 2025 · 05:00 PM ET
Watch
Research Pacific Edge Limited
Pacific Edge Limited company profile
View the public company page for Pacific Edge Limited on 6ix.
Pacific Edge Limited news
Read company news and market updates connected to Pacific Edge Limited.
Pacific Edge Limited investor events
Find investor webinars, events, and replay context for Pacific Edge Limited.
Alternate listings
PEB:ASX
AU · AUD
Alternate listing for Pacific Edge Limited; the primary context on this page is PEB:NZX.
PFGTF:OTC
US · USD
Alternate listing for Pacific Edge Limited; the primary context on this page is PEB:NZX.
CY3:FWB
DE · EUR
Alternate listing for Pacific Edge Limited; the primary context on this page is PEB:NZX.